Wednesday, May 22, 2013

• Celldex Therapeutics to Present at Two Upcoming Investor ConferencesGlobeNewswire( (Wed, May 22)

Monday, May 6, 2013

• Celldex Therapeutics Announces Upcoming Presentation at the Credit Suisse 2013 Antibody DayGlobeNewswire( (Mon, May 6)

Thursday, May 2, 2013

• Celldex Reports First Quarter 2013 Financial ResultsGlobeNewswire( (Thu, May 2)

Monday, April 8, 2013

• Celldex Presents CDX-1127 In Vitro Human Data Consistent With Strong Potency and Safety Profile at AACR 2013GlobeNewswire( (Mon, Apr 8)

Monday, March 11, 2013

• Outlook for Diagnostic Substances IndustryMarketwired( (Mon, Mar 11)

Thursday, March 7, 2013

• Celldex Reports Fourth Quarter and Fiscal 2012 Financial ResultsGlobeNewswire( (Thu, Mar 7)

Thursday, February 28, 2013

• Celldex Therapeutics to Report Fourth Quarter and Fiscal 2012 Financial Results and Host Corporate 2013 Strategic Outlook CallGlobeNewswire( (Thu, Feb 28)

Thursday, February 14, 2013

• U.S. Food and Drug Administration Approved 30% More Drugs in 2012Marketwired( (Thu, Feb 14)

Thursday, January 24, 2013

• Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013Marketwired( (Thu, Jan 24)

Tuesday, December 11, 2012

• Celldex Therapeutics’ CDX-301 Safely Mobilizes Hematopoietic Cells in Phase 1 Study; Future Development PlannedBusiness Wire( (Tue, Dec 11)

Saturday, December 8, 2012

• Final Data from Celldex Therapeutic’s CDX-011 Phase 2 Study in Metastatic Breast Cancer Supports Overall Survival Benefit in Patients with High GPNMB ExpressionBusiness Wire( (Sat, Dec 8)

Friday, December 7, 2012

• Celldex Therapeutics Announces Upcoming Presentation at Oppenheimer Healthcare ConferenceBusiness Wire( (Fri, Dec 7)

Wednesday, December 5, 2012

• Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry's Success in 2012Marketwired( (Wed, Dec 5)